Management

Jennifer K Simpson, Ph.D., MSN, CRNP
President and Chief Executive Officer

Dr. Simpson joined Panbela as President and Chief Executive Officer in July of 2020 and was also appointed as a Director at that time. She brings to the Company more than 12 years’ experience in pharmaceutical executive leadership, global marketing and product commercialization. Most recently Dr. Simpson was the CEO of Delcath (Nasdaq:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancer.

Read more

Susan Horvath
Vice President and Chief Financial Officer

Ms. Horvath has held both finance and operating positions within pharmaceutical, healthcare and consumer organizations.  In addition to her position with the Company, Ms. Horvath sits on the board of directors and provides financial consulting services for Photonic Pharma, LLC, a privately held company focused on efficiencies in early stage drug discovery. Most recently she served as Chief Financial Officer of Eyebobs, LLC, a private company focused on the reading glasses industry.

Read more

Elizabeth Bruckheimer, Ph.D.
Vice President and Chief Scientific Officer

Dr. Elizabeth Bruckheimer joined Panbela as Vice President and Chief Scientific Officer in June 2022. Her professional career spans 20 years in oncology research, the biotech/pharmaceutical industry, and contract research organizations. In those endeavors, she led cross-functional preclinical/translational drug development programs, laboratory/organizational operations, regulatory affairs, project management, and business development activities.

Read more

Ashok Chavan, Ph.D.
Vice President of CMC, Quality and Supply Chain

Dr. Chavan has extensive experience in pharmaceutical product development and product approval process with regulatory agencies having been involved in approval of Subsys, Syndros and Dronabinol Capsules. Prior to joining Panbela, Dr. Ashok served as  VP of CMC, QA and Supply Chain for Cancer Prevention Pharmaceuticals from 2020 to 2022.

Read more

Rachel Bragg, MPH
Vice President of Clinical Development

Mrs. Bragg joined Panbela as Vice President of Clinical Development in June of 2021.  She brings to the company ~20 years’ experience in pharmaceutical research which spans the biotech, pharma and CRO markets.  Most recently Mrs. Bragg was the Therapeutic Area Head of Hematology Oncology for Product Delivery at PPD focusing on global program and trial strategy for various indications within hematology and oncology drug development.

Read more

Tammy Groene
Vice President of Operations

Since April 2012, Ms. Groene has provided operational management and administrative support to the Panbela team. Prior to joining Panbela Therapeutics, Inc., Ms. Groene worked for MGI Pharma, Inc. as the Executive Assistant to the Chief Medical Officer then transitioned into the Marketing Department. Ms. Groene earned her Bachelor of Science degree from St. Cloud State University in St. Cloud, Minnesota.

Anthony L. Kiorpes, Ph.D., DVM
Toxicology Consultant

Andy Kiorpes is a graduate of Columbia University (BA Biology, 1970), the University of Wisconsin-Madison (MS Veterinary Science, 1974; PhD Physiology, 1977) Kansas State University (DVM, 1982), and the University of Arkansas (MBA, 1999). He has over 22 years of experience as a toxicologist working in food, pharmaceutical, and medical device development and safety.

Read more

Michael Walker, M.D.
Pancreatic Research Consultant

Dr. Michael Walker obtained his BS (Biochemistry) and MD degrees from the University of Minnesota. He completed his General Surgery residency and a 2-year American Cancer Society clinical and research fellowship at UCLA, focusing on pancreatic islets and their molecular physiology. Before joining Panbela, he practiced General Surgery in Minnesota.

Read more